Differences in the distribution of polymorphisms among NOS and EDN gene families suggest that these SNPs could play a contributory role in the pathophysiology and risk of OSA-induced cardiovascular morbidity. This evidence concerns the gene NOS2 and obstructive sleep apnea syndrome.